A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation Status in Patients With Chronic Lymphocytic Leukemia (CLL).
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Vincristine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Pharmacodynamics
- 12 May 2015 Biomarkers information updated
- 24 Jun 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 24 Jun 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.